Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia

Brain Research

Volumn 1121, Issue 1, 2006, Pages 207-215

  Micale, Vincenzo ^a   Marco Leggio, Gian ^a   Mazzola, Carmen ^a   Drago, Filippo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Active and passive avoidance; Animal models of amnesia; Radial maze test; Serotonin 5 HT4 receptor

Indexed keywords

5 (8 AMINO 7 CHLORO 2,3 DIHYDRO 1,4 BENZODIOXIN 5 YL) 3 [1 (2 PHENYLETHYL) 4 PIPERIDINYL] 1,3,4 OXADIAZOL 2(3H) ONE MONOHYDROCHLORIDE; AMYLOID BETA PROTEIN[1-42]; CARBON MONOXIDE; GALANIN; IBOTENIC ACID; METHYLAZOXYMETHANOL; PARTIAL AGONIST; SEROTONIN 4 AGONIST; SEROTONIN 4 RECEPTOR; SL 650155; UNCLASSIFIED DRUG;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; COGNITION; CONTROLLED STUDY; EXPERIMENTAL TEST; FEMALE; LEARNING; MALE; MAZE TEST; MEMORY; MOUSE; NONHUMAN; OLIVARY NUCLEUS; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT; TASK PERFORMANCE;

AMNESIA; ANIMALS; AVOIDANCE LEARNING; COGNITION; DIOXANES; DISEASE MODELS, ANIMAL; MAZE LEARNING; MICE; OXADIAZOLES; REACTION TIME;

ANIMALIA;

EID: 33750709697     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.08.108     Document Type: Article

References (75)

1. Altman H.J., and Normile H.J. Different temporal effects of serotonergic antagonists on passive avoidance retention. Pharmacol. Biochem. Behav. 28 (1987) 353-359
2. Arendash G.W., Gordon M.N., Diamond D.M., Austin L.A., Hatcher J.M., Jantzen P., DiCarlo G., Wilcock D., and Morgan D. Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory. DNA Cell Biol. 20 (2001) 737-744
3. Barnes N.M., and Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999) 1083-1152
4. Bartus R.T., Dean III R.L., Beer B., and Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 217 (1982) 408-417
5. Bierer L.M., Haroutunian V., Gabriel S., Knott P.J., Carlin L.S., Purohit D.P., Perl D.P., Schmeidler J., Kanof P., and Davis K.L. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J. Neurochem. 64 (1995) 749-760
6. Bockaert J., Claeysen S., Compan V., and Dumuis A. 5-HT4 receptors. Curr. Drug Targets CNS Neurol. Disord. 3 (2004) 39-51
7. Bohus B., and De Wied D. Actions of ACTH- and MSH-like peptides on learning, performance and retention. In: Martinez J.L., Jensen R.A., Messing R.B., Riger H., and McGaugh J.L. (Eds). Endogenous Peptides and Learning and Memory Processes (1981), Academic Press, New York 59-775
8. Bowser R., Kordower J.H., and Mufson E.J. A confocal microscopic analysis of galaninergic hyperinnervation of cholinergic basal forebrain neurons in Alzheimer's disease. Brain Pathol. 7 (1997) 723-730
9. Buhot M.C., Martin S., and Segu L. Role of serotonin in memory impairment. Ann. Med. 32 (2000) 210-221
10. Cattabeni F., and Di Luca M. Developmental models of brain dysfunctions induced by targeted cellular ablations with methylazoxymethanol. Physiol. Rev. 77 (1997) 199-215
11. Chen C.P., Alder J.T., Bowen D.M., Esiri M.M., McDonald B., Hope T., Jobst K.A., and Francis P.T. Presynaptic serotonergic markers in community-acquired cases of Alzheimer's disease: correlations with depression and neuroleptic medication. J. Neurochem. 66 (1996) 1592-1598
12. Chen C.P., Eastwood S.L., Hope T., McDonald B., Francis P.T., and Esiri M.M. Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer's disease prospectively assessed for behavioural changes. Neuropathol. Appl. Neurobiol. 26 (2000) 571-572
13. Coyle J.T., Donald L.P., and Delong M.R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219 (1983) 1184-1190
14. Crawley J.N. Minireview. Galanin-acetylcholine interactions: relevance to memory and Alzheimer's disease. Life Sci. 58 (1996) 2185-2199
15. Cross A.J., Crow T.J., Johnson J.A., Joseph M.H., Perry E.K., Perry R.H., Blessed G., and Tomlinson B.E. Monoamine metabolism in senile dementia of Alzheimer type. J. Neurol. Sci. 60 (1983) 383-392
16. Cummings J.L. Cognitive and behavioral heterogeneity in Alzheimer's disease: seeking the neurobiological basis. Neurobiol. Aging 21 (2000) 845-861
17. Curcio C.A., and Kemper T. Nucleus raphe dorsalis in the dementia of the Alzheimer-type: neurofibrillary changes and neuronal packing density. J. Neuropathol. Exp. Neurol. 43 (1984) 359-368
18. Dekker A.J., Gage F.H., and Thal L.J. Delayed treatment with nerve growth factor improves acquisition of a spatial task in rats with lesions of the nucleus basalis magnocellularis: evaluation of the involvement of different neurotransmitter systems. Neuroscience 48 (1992) 111-119
19. Eglen R.M., Wong E.H., Dumuis A., and Bockaert J. Central 5-HT4 receptors. Trends Pharmacol. Sci. 16 (1995) 391-398
20. Fiore M., Talamini L., Angelucci F., Koch T., Aloe L., and Korf J. Prenatal methylazoxymethanol acetate alters behavior and brain NGF levels in young rats: a possible correlation with the development of schizophrenia-like deficits. Neuropharmacology 38 (1999) 857-869
21. Fiore M., Korf J., Antonelli A., Talamini L., and Aloe L. Long-lasting effects of prenatal MAM treatment on water maze performance in rats: associations with altered brain development and neurotrophin levels. Neurotoxicol. Teratol. 24 (2000) 179-191
22. Flood J.F., and Cherkin A. Fluoxetine enhances memory processing in mice. Psychopharmacology 93 (1987) 36-43
23. Fontana D.J., Daniels S.E., Wong E.H., Clark R.D., and Eglen R.M. The effects of novel, selective 5-hydroxytryptamine (5-HT)4 receptor ligands in rat spatial navigation. Neuropharmacology 36 (1987) 689-696
24. Galeotti N., Ghelardini C., and Bartolini A. Role of 5-HT4 receptors in the mouse passive avoidance test. J. Pharmacol. Exp. Ther. 286 (1998) 1115-1121
25. Gottfries C.G. Neurochemical aspects on aging and diseases with cognitive impairment. J. Neurosci. Res. 27 (1990) 541-547
26. Haley T.J., and Mccormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. 12 (1957) 12-15
27. Hellweg R., Gericke C.A., Jendroska K., Hartung H.D., and Cervos-Navarro J. NGF content in the cerebral cortex of non-demented patients with amyloid-plaques and in symptomatic Alzheimer's disease. Int. J. Dev. Neurosci. 16 (1998) 787-794
28. Hökfelt T., Wiesenfeld-Hallin Z., Villar M., and Melander T. Increase of galanin-like immunoreactivity in rat dorsal root ganglion cells after peripheral axotomy. Neurosci. Lett. 83 (1987) 217-220
29. Howlett D.R., Richardson J.C., Austin A., Parsons A.A., Bate S.T., Davies D.C., and Gonzalez M.I. Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes. Brain Res. 1017 (2004) 130-136
30. Hoyer D., Hannon J.P., and Martin G.R. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav. 71 (2002) 533-554
31. Ishimaru H., Nabeshima T., Katoh A., Suzuki H., Fukuta T., and Kameyama T. Effects of successive carbon monoxide exposures on delayed neuronal death in mice under the maintenance of normal body temperature. Biochem. Biophys. Res. Commun. 179 (1991) 836-840
32. Ishimaru H., Katoh A., Suzuki H., Fukuta T., Kameyama T., and Nabeshima T. Effects of N-methyl-d-aspartate receptor antagonists on carbon monoxide-induced brain damage in mice. J. Pharmacol. Exp. Ther. 261 (1992) 349-352
33. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., and Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325 (1987) 733-736
34. Kinney J.W., Starosta G., and Crawley J.N. Central galanin administration blocks consolidation of spatial learning. Neurobiol. Learn. Mem. 80 (2003) 42-54
35. Kwo-On-Yuen P.F., Mandel R., Chen A.D., and Thal L.J. Tetrahydroaminoacridine improves the spatial acquisition deficit produced by nucleus basalis lesions in rats. Exp. Neurol. 108 (1990) 221-228
36. Lai M.K., Tsang S.W., Francis P.T., Esiri M.M., Hope T., Lai O.F., Spence I., and Chen C.P. [3H]GR113808 binding to serotonin 5-HT(4) receptors in the postmortem neocortex of Alzheimer disease: a clinicopathological study. J. Neural Transm. 110 (2003) 779-788
37. Langlois M., and Fischmeister R. 5-HT4 receptor ligands: applications and new prospects. J. Med. Chem. 46 (2003) 319-344
38. Lelong V., Lhonneur L., Dauphin F., and Boulouard M. BIMU 1 and RS 67333, two 5-HT4 receptor agonists, modulate spontaneous alternation deficits induced by scopolamine in the mouse. Naunyn-Schmiedeberg's Arch. Pharmacol. 367 (2003) 621-628
39. Le Pen G., Grottick A.J., Higgins G.A., Martin J.R., Jenck F., and Moreau J.L. Spatial and associative learning deficits induced by neonatal excitotoxic hippocampal damage in rats: further evaluation of an animal model of schizophrenia. Behav. Pharmacol. 11 (2000) 257-268
40. Letty S., Child R., Dumuis A., Pantaloni A., Bockaert J., and Rondouin G. 5-HT4 receptors improve social olfactory memory in the rat. Neuropharmacology 36 (1997) 681-687
41. Lezoualc'h F., and Robert S.J. The serotonin 5-HT4 receptor and the amyloid precursor protein processing. Exp. Gerontol. 38 (2003) 159-166
42. Lyness S.A., Zarow C., and Chui H.C. Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis. Neurobiol. Aging 24 (2003) 1-23
43. Mandel R.J., Chen A.D., Connor D.J., and Thal L.J. Continuous physostigmine infusion in rats with excitotoxic lesions of the nucleus basalis magnocellularis: effects on performance in the water maze task and cortical cholinergic markers. J. Pharmacol. Exp. Ther. 251 (1989) 612-619
44. Manuel-Apolinar L., Rocha L., Pascoe D., Castillo E., Castillo C., and Meneses A. Modifications of 5-HT4 receptor expression in rat brain during memory consolidation. Brain Res. 1042 (2005) 73-81
45. Matsumoto M., Togashi H., Mori K., Ueno K., Ohashi S., Kojima T., and Yoshioka M. Evidence for involvement of central 5-HT(4) receptors in cholinergic function associated with cognitive processes: behavioral, electrophysiological, and neurochemical studies. J. Pharmacol. Exp. Ther. 296 (2001) 676-682
46. Maurice T., Lockhart B.P., and Privat A. Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction. Brain Res. 706 (1996) 181-193
47. Maurice T., Phan V.L., Noda Y., Yamada K., Privat A., and Nabeshima T. The attenuation of learning impairments induced after exposure to CO or trimethyltin in mice by sigma (sigma) receptor ligands involves both sigma1 and sigma2 sites. Br. J. Pharmacol. 127 (1999) 335-342
48. 1 receptor blockade. Eur. J. Pharmacol. 477 (2003) 219-225
49. Medhurst A.D., Lezoualc'h F., Fischmeister R., Middlemiss D.N., and Sanger G.J. Quantitative mRNA analysis of five C-terminal splice variants of the human 5-HT4 receptor in the central nervous system by TaqMan real time RT-PCR. Brain Res. Mol. Brain Res. 90 (2001) 125-134
50. Meltzer C.C., Smith G., DeKosky S.T., Pollock B.G., Mathis C.A., Moore R.Y., D.J. Kupfer D.J., and Reynolds III C.F. Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology 18 (1998) 407-430
51. Meneses A. 5-HT system and cognition. Neurosci. Biobehav. Rev. 23 (1999) 1111-1125
52. Meneses A. Involvement of 5-HT(2A/2B/2C) receptors on memory formation: simple agonism, antagonism, or inverse agonism?. Cell. Mol. Neurobiol. 22 (2002) 675-688
53. Meneses A. Effects of the 5-HT7 receptor antagonists SB-269970 and DR 4004 in autoshaping Pavlovian/instrumental learning task. Behav. Brain Res. 155 (2004) 275-282
54. Meneses A., and Hong E. Effect of fluoxetine on learning and memory involves multiple 5-HT systems. Pharmacol. Biochem. Behav. 52 (1995) 341-346
55. Moser P.C., Bergis O.E., Jegham S., Lochead A., Duconseille E., Terranova J.P., Caille D., Berque-Bestel I., Lezoualc'h F., Fischmeister R., Dumuis A., Bockaert J., George P., Soubrie P., and Scatton B. SL65.0155, a novel 5-hydroxytryptamine(4) receptor partial agonist with potent cognition-enhancing properties. J. Pharmacol. Exp. Ther. 302 (2002) 731-741
56. Mufson E.J., Cochran E., Benzing W., and Kordower J.H. Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the stria terminalis in aging, Alzheimer's disease and Down's syndrome. Dementia 4 (1993) 237-250
57. Nabeshima T., Katoh A., Ishimaru H., Yoneda Y., Ogita K., Murase K., Ohtsuka H., Inari K., Fukuta T., and Kameyama T. Carbon monoxide-induced delayed amnesia, delayed neuronal death and change in acetylcholine concentration in mice. J. Pharmacol. Exp. Ther. 256 (1991) 378-384
58. Nicoletti F., Valerio C., Pellegrino C., Drago F., Scapagnini U., and Canonico P.L. Spatial learning potentiates the stimulation of phosphoinositide hydrolysis by excitatory amino acids in rat hippocampal slices. J. Neurochem. 51 (1988) 725-729
59. Orsetti M., Dellarole A., Ferri S., and Ghi P. Acquisition, retention, and recall of memory after injection of RS67333, a 5-HT(4) receptor agonist, into the nucleus basalis magnocellularis of the rat. Learn. Mem. 10 (2003) 420-426
60. Palmer A.M. Neurochemical studies of Alzheimer's disease. Neurodegeneration 5 (1996) 381-391
61. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed. (1986), Academic press, London
62. Perez-Garcia G., and Meneses A. Oral administration of the 5-HT6 receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task. Pharmacol. Biochem. Behav. 81 (2005) 673-682
63. Reynolds G.P., Mason S.L., Meldrum A., De Keczer S., Parnes H., Eglen R.M., and Wong E.H. 5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases. Br. J. Pharmacol. 114 (1995) 993-998
64. Roychowdhury S., Haas H., and Anderson E.G. 5-HT1A and 5-HT4 receptor colocalization on hippocampal pyramidal cells. Neuropharmacology 33 (1994) 551-557
65. Rylett R.J., and Williams L.R. Role of neurotrophins in cholinergic-neurone function in the adult and aged CNS. Trends Neurosci. 17 (1994) 486-490
66. Selkoe D.J., and Podlisny M.B. Deciphering the genetic basis of Alzheimer's disease. Annu. Rev. Genomics Hum. Genet. 3 (2002) 67-99
67. Spencer J.P., Brown J.T., Richardson J.C., Medhurst A.D., Sehmi S.S., Calver A.R., and Randall A.D. Modulation of hippocampal excitability by 5-HT4 receptor agonists persists in a transgenic model of Alzheimer's disease. Neuroscience 129 (2004) 49-54
68. Steiner R.A., Hohmann J.G., Holmes A., Wrenn C.C., Cadd G., Jureus A., Clifton D.K., Luo M., Gutshall M., Ma S.Y., Mufson E.J., and Crawley J.N. Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 4184-4189
69. Torres G.E., Chaput Y., and Andrade R. Cyclic AMP and protein kinase A mediate 5-hydroxytryptamine type 4 receptor regulation of calcium-activated potassium current in adult hippocampal neurons. Mol. Pharmacol. 47 (1995) 191-197
70. Venault P., Chapouthier G., de Carvalho L.P., Simiand J., Morre M., Dodd R.H., and Rossier J. Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks. Nature 321 (1986) 864-866
71. Waeber C., Sebben M., Grossman C., Javoy-Agid F., Bockaert J., and Dumuis A. [3H]-GR113808 labels 5-HT4 receptors in the human and guinea-pig brain. NeuroReport 4 (1993) 1239-1242
72. Wood G.K., Quirion R., and Srivastava L.K. Early environment contributes to developmental disruption of MPFC after neonatal ventral hippocampal lesions in rats. Synapse 50 (2003) 223-232
73. Yamada K., Tanaka T., Han D., Senzaki K., Kameyama T., and Nabeshima T. Protective effects of idebenone and alpha-tocopherol on beta-amyloid-(1-42)-induced learning and memory deficits in rats: implication of oxidative stress in beta-amyloid-induced neurotoxicity in vivo. Eur. J. Neurosci. 11 (1999) 83-90
74. Yamamoto T., and Hirano A. Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons. Ann. Neurol. 17 (1985) 573-577
75. Yang J.Q., and Zhou Q.X. Protective effect of nimodipine against cerebral injury induced by subacute carbon monoxide intoxication in mice. Acta Pharmacol. Sin. 22 (2001) 423-427